Using a novel approach, the medical team employed a cardiac occluder device, typically used in heart surgeries, to seal the fistulas, offering a new treatment option for this challenging condition.

Merit Medical Systems has enrolled the first patient in the multi-centre PREEMIE study to assess the efficacy and safety of the Bloom Micro Occluder System, aimed at treating patent ductus arteriosus ...

prospective study of the Bloom Micro Occluder System for the treatment of patent ductus arteriosus (PDA) in premature infants (PREEMIE study). PDA is a congenital heart condition that occurs when ...

Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced enrollment of the first patient in its multicenter, prospective study of the Bloom Micro Occluder ...